These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11681240)

  • 1. [Standard therapy of CPT-11 for colorectal cancer].
    Saitoh S; Sakata Y
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1345-51. PubMed ID: 11681240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of CPT-11 and bolus 5-FU/ l-leucovorin in patients with metastatic colorectal cancer.
    Fujishima H; Kikuchi I; Miyanaga O; Ueda A; Baba E; Mitsugi K; Harada M; Nakano S
    Int J Clin Oncol; 2004 Apr; 9(2):92-7. PubMed ID: 15108040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irinotecan in the treatment of colorectal cancer: clinical overview.
    Vanhoefer U; Harstrick A; Achterrath W; Cao S; Seeber S; Rustum YM
    J Clin Oncol; 2001 Mar; 19(5):1501-18. PubMed ID: 11230497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irinotecan-based combinations for the adjuvant treatment of stage III colon cancer.
    Saltz L
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):47-50. PubMed ID: 11200149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Irinotecan plus fluorouracil and folinic acid in metastatic colorectal cancer].
    Krieger G
    Strahlenther Onkol; 2001 Jun; 177(6):316-8. PubMed ID: 11446323
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current evidence of irinotecan combination chemotherapy with TS-1 in patients with advanced colorectal cancer].
    Goto A
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):896-900. PubMed ID: 16835475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controversy of treatment for advanced colorectal cancer--intermedisine].
    Sato A; Shimada K; Taguchi S
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1260-9. PubMed ID: 14518404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antitumor activity of irinotecan in combination with 5-fluorouracil in rats bearing advanced colorectal cancer: role of drug sequence and dose.
    Cao S; Rustum YM
    Cancer Res; 2000 Jul; 60(14):3717-21. PubMed ID: 10919639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irinotecan and high-dose fluorouracil/leucovorin for metastatic colorectal cancer.
    Douillard JY;
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):51-5. PubMed ID: 11200150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CPT-11 combined chemotherapy for metastatic gastric cancer].
    Narahara H; Sugimoto N; Iishi H; Tatsuta M
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1973-7. PubMed ID: 15570923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [FOLFIRI regimen for metastatic or recurrent colorectal cancer].
    Uemura N; Yamada Y
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):904-6. PubMed ID: 16835477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in chemotherapy for colorectal cancer].
    Sasaki T; Maeda Y
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2185-92. PubMed ID: 11142161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Four cases of advanced colorectal cancer successfully treated with irinotecan plus 5-fluorouracil and l-leucovorin combination chemotherapy].
    Kamoshita N; Makita F; Aiba M; Tokiniwa H; Nagashima T; Takeyoshi I; Ohwada S; Morishita Y
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1187-90. PubMed ID: 16121927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trial.
    Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kourousis C; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V
    Dig Dis; 2007; 25(1):100-5. PubMed ID: 17384515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CPT-11 (irinotecan) and 5-fluorouracil: a promising combination for therapy of colorectal cancer.
    Saltz L; Shimada Y; Khayat D
    Eur J Cancer; 1996; 32A Suppl 3():S24-31. PubMed ID: 8943662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential administration of 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) at relapse versus CPT-11 followed by 5-FU/LV in advanced colorectal carcinoma. A phase III randomized study.
    Tsavaris N; Kosmas C; Skopelitis H; Papadoniou N; Polyzos A; Zografos G; Adoniou E; Gryniatsos J; Felekouras E; Zacharakis M; Sigala F; Bacoyiannis C; Papastratis G; Papalambros E
    Chemotherapy; 2007; 53(4):282-91. PubMed ID: 17496414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.
    Rosati G; Tucci A; Rinaldi A; Colarusso D; Pizza C; Reggiardo G; Manzione L
    Oncology; 2004; 66(5):371-8. PubMed ID: 15331924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Irinotecan in combination for colon cancer].
    Ducreux M; Gil-Delgado M; André T; Ychou M; de Gramond A; Khayat D
    Bull Cancer; 1998 Dec; Spec No():43-6. PubMed ID: 9932084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer.
    Falcone A; Masi G; Allegrini G; Danesi R; Pfanner E; Brunetti IM; Di Paolo A; Cupini S; Del Tacca M; Conte P
    J Clin Oncol; 2002 Oct; 20(19):4006-14. PubMed ID: 12351598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irinotecan/5-FU/leucovorin, oxaliplatin/5-FU/leucovorin, and oxaliplatin/irinotecan are each effective in the treatment of 5-FU-resistant advanced colorectal cancer.
    Fisher MD
    Clin Colorectal Cancer; 2001 Aug; 1(2):85-6. PubMed ID: 12445365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.